How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | MEDPMedpace Holdings, Inc. | IQVIQVIA HOLDINGS INC. | WATWATERS CORP /DE/ | ILMNILLUMINA, INC. | Median of the restexcluding MEDP |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $662.48▲ 40.05 (6.43%) | $276.63▲ 8.78 (3.28%) | $457.47▲ 14.64 (3.31%) | $282.86▲ 14.93 (5.57%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 7.3/10 | 6.0/10 | 9.0/10 | 6.0/10 | 6.0/10 |
| Market value | $18.80B | $46.92B | $27.24B | $43.28B | |
| Revenue | $2.53B | $16.31B | $3.17B | $4.34B | |
| Profit | $451.1M | $1.36B | $642.6M | $850.0M | |
| Revenue growthChange in sales versus the prior year. | 20.0% | 5.9% | 7.0% | -0.7% | 5.9% |
| Gross marginShare of sales left after the direct cost of producing them. | — | 33.3% | 59.3% | 66.1% | 59.3% |
| Operating marginShare of sales left after running the business, before interest and tax. | 21.1% | 13.4% | 25.4% | 18.6% | 18.6% |
| Profit marginProfit kept from each dollar of sales. | 17.8% | 8.3% | 20.3% | 19.6% | 19.6% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 26.9% | 12.6% | 17.1% | 21.4% | 17.1% |
| Return on equityProfit against the owners' stake in the company. | 98.3% | 20.9% | 25.1% | 31.2% | 25.1% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | 9.2% | 23.4% | 48.4% | 23.4% |
| P/E ratioPrice paid per dollar of annual profit. | 41.66x | 34.50x | 42.39x | 50.91x | 42.39x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | 18.24x | 30.99x | — | 24.61x |
| Price to book | 40.94x | 7.21x | 10.64x | 15.89x | 10.64x |
| Debt to equityTotal liabilities compared with owners' stake. | 3.30x | 3.59x | 0.98x | 1.44x | 1.44x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 6/7 | 5/9 | 6/9 | 7/8 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | distress | grey | safe | safe |
How MEDP compares with the others
- MEDP's operating margin of 21.1% is higher than the median of the other companies selected (18.6%).
- Its revenue grew faster than the median of the other companies selected: 20.0% against 5.9%.
- It trades at a P/E in line with the median of the other companies selected (41.7x against 42.4x).
- Its liabilities are higher relative to equity than the median of the other companies selected: 3.3x against 1.4x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.